Uracil-(2-13C) is a pyrimidone and a (13)C-modified compound. Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 13C-URACIL and URACIL 2C-13. Its PubChem CID is 10171240.
Uracil C-13, 2-
| CAS No | 35803-45-3 |
|---|---|
| Molecular Formula | C4H4N2O2 |
| Molecular Weight | 113.08 g/mol |
| Synonyms | (213C)1H-pyrimidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Uracil-(2-13C) is a pyrimidone and a (13)C-modified compound. Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).
The listed CAS number is 35803-45-3.
The listed molecular formula is C4H4N2O2.
The listed molecular weight is 113.08 g/mol.
(213C)1H-pyrimidine-2,4-dione.
The source lists 13C-URACIL and URACIL 2C-13.